| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 18 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 740.5K | $19.85M | - | |
| Other | 150.2K | $4.03M | - | |
| Other | 127.6K | $3.42M | - | |
| Other | 120.2K | $3.22M | - | |
| CFO | 86.0K | $2.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $34.35 | $75,572.23 | -0.3% | |
| Feb 1, 2021 | Smither John W65 | Chief Financial Officer | Sale+OE | 5,000 | $35.00 | $175,000.00 | -4.2% | |
| Feb 1, 2021 | Chaudhuri Bhaskar78 | Director | Sell | 10,000 | $33.22 | $332,206.75 | -0.6% | |
| Jan 19, 2021 | Smither John W65 | Chief Financial Officer | Sale+OE | 1,750 | $30.00 | $52,500.00 | -1.5% | |
| Jan 4, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $27.82 | $61,214.56 | -1.2% | |
| Dec 14, 2020 | Smither John W65 | Chief Financial Officer | Sale+OE | 5,250 | $30.00 | $157,500.00 | -4.2% | |
| Dec 14, 2020 | Osborne David W76 | Chief Technical Officer | Sell | 15,000 | $30.00 | $450,000.00 | -5.6% | |
| Dec 1, 2020 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $25.98 | $57,154.57 | -0.4% | |
| Nov 2, 2020 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $18.27 | $40,186.08 | -1.2% | |
| Oct 2, 2020 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 496,000 | $25.00 | $12,400,000.00 | +10.6% |